BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- EBITDA, 2025
- $5.0B
- YoY, 2025
- +28.6%
- 5-year CAGR
- +36.7%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $5.0B | +28.6% |
| 2024 | $3.9B | +9.4% |
| 2023 | $3.5B | +27.1% |
| 2022 | $2.8B | +21.5% |
| 2021 | $2.3B | +119.8% |
| 2020 | $1.0B | −43.0% |
| 2019 | $1.8B | +1.5% |
| 2018 | $1.8B | +15.2% |
| 2017 | $1.6B | +118.1% |
| 2016 | $717M | — |
| 2015 | −$9.0M | — |
| 2014 | −$14M | — |
| 2013 | $399M | — |
| 2012 | −$3.6B | — |
| 2011 | $1.2B | — |
| 2010 | −$353M | — |
| 2009 | −$571M | — |
| 2008 | −$641M | — |
| 2007 | $904M | — |